TP53 and neurodegenerative disease: Regarding the differences between CBD and THC treatment groups, CBD showed a decreased abundance of proteins involved in pathways related to neurodegenerative diseases, and an increased abundance in the complement and coagulation cascades, p53 signaling pathway, necroptosis, and ECM–receptor interactions.